NetworkNewsBreaks – Marijuana Company of America
Post# of 969
(Total Views: 363)
Posted On: 03/15/2019 3:54:36 PM
NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Grabs Stronger Position in U.S. Hemp-Based Product Market with Patented hempSMART Brain
Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) recently received a U.S. patent for its hempSMART Brain that places it in a decidedly stronger position in the U.S. hemp-based product market, forecast to reach nearly $2 billion in three years. A recent article discussing the company’s flagship CBD product reads, “MCOA’s hempSMART Brain is a unique product in that it utilizes a synergistic blend of natural neuroprotective and neuro-regenerative compounds, including CBD, in clinically researched and verified therapeutic amounts. Clinical studies indicate that CBD facilitates brain recovery by aiding in normal cell production. The human brain is ‘fitted’ with natural specialized receptors for CBD, part of the endocannabinoid system that maintains homeostasis, or a stable internal environment in the body, as the external environment changes. Spurred by changes in the legislative environment, research into the use of cannabinoids to supplement neurologic and neurodegenerative concerns has been increasing, with encouraging results.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Innovative hemp and cannabis corporation Marijuana Company of America (OTCQB: MCOA) recently received a U.S. patent for its hempSMART Brain that places it in a decidedly stronger position in the U.S. hemp-based product market, forecast to reach nearly $2 billion in three years. A recent article discussing the company’s flagship CBD product reads, “MCOA’s hempSMART Brain is a unique product in that it utilizes a synergistic blend of natural neuroprotective and neuro-regenerative compounds, including CBD, in clinically researched and verified therapeutic amounts. Clinical studies indicate that CBD facilitates brain recovery by aiding in normal cell production. The human brain is ‘fitted’ with natural specialized receptors for CBD, part of the endocannabinoid system that maintains homeostasis, or a stable internal environment in the body, as the external environment changes. Spurred by changes in the legislative environment, research into the use of cannabinoids to supplement neurologic and neurodegenerative concerns has been increasing, with encouraging results.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)